(MENAFN) Oman's Salalah Free Zone (SFZ) and US-based Flex Pharmaceuticals, a biotechnology company, lately contracted to build an international complex for pharmaceutical industries at a cost of USD365 million, said a report.
The plant will make more than 100 compound drugs, the complex is a strategic partnership between Abela International and Arab Group for Investment in SFZ, reported Times of Oman.
This project will create 300 job opportunities for young Omani males and females, involving a research and development center and world-class labs
MENAFN0901201800450000ID1096329046
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.